Netupitant is an antiemitic drug. In the United States, the combination drug netupitant/palonosetron (trade name Akynzeo) is approved by the Food and Drug Administration for prevention of acute and delayed chemotherapy-induced nausea and vomiting, including highly emetogenic chemotherapy such as with cisplatin. In Europe, it is approved by the European Medicines Agency for the same indication.

CAS：290297-26-6
中文别名：
英文别名：Netupitant;2-[3,5-bis(trifluoromethyl)phenyl]-N,2-dimethyl-N-[4-(2-methylphenyl)-6-(4-methylpiperazin-1-yl)pyridin-3-yl]propanamide;UNII-7732P08TIR;Netupitan;
分子式：C30H32F6N4O
分子量：578.592
精确质量：578.248
Psa：39.68
Logp：6.7899

MDL号：MFCD25976831

密度：1.255
沸点：597.4ºC at 760 mmHg
闪点：315.1ºC
折射率：1.539
蒸汽压：3.09E-14mmHg at 25°C